Results 111 to 120 of about 107,461 (265)

Systems thinking as a framework for analyzing commercial determinants of health [PDF]

, 2018
Policy Points: • Worldwide, more than 70% of all deaths are attributable to noncommunicable diseases (NCDs), nearly half of which are premature and apply to individuals of working age.
Katikireddi, Srinivasa Vittal, Capewell, S, PATRICK FAFARD, Cummins, Steven, JØRGEN DEJGÅRD JENSEN, Weishaar, H, Mwatsama, M, ELIZABETH EASTMURE, Orford, J., Cassidy, Rebecca, Petticrew, M., Petticrew, M, Cassidy, R, JIM ORFORD, Orford, J, Orford, Jim, MARK PETTICREW, Knai, C, BENJAMIN HAWKINS, Mays, Nicholas, Cummins, S, Mwatsama, M., Mays, N., Eastmure, E, Jensen, Jørgen Dejgård, SIMON CAPEWELL, Eastmure, E., MODI MWATSAMA, Petticrew, Mark, STEVEN CUMMINS, Knai, Cécile, Jensen, J., Katikireddi, SV, Katikireddi, S.V., Mwatsama, Modi, Fafard, P., Cummins, S., Hawkins, Benjamin, Weishaar, H., Jensen, JD, Cassidy, R., Eastmure, Elizabeth, Weishaar, Heide, REBECCA CASSIDY, Hawkins, B., Hawkins, B, SRINIVASA VITTAL KATIKIREDDI, CÉCILE KNAI, Capewell, S., Fafard, P, Fafard, Patrick, Knai, C., Mays, N, NICHOLAS MAYS, Capewell, Simon, HEIDE WEISHAAR   +55 more
core   +1 more source

CX3CL1 in Early Detection of Alzheimer's Disease: Plasma Dynamics Across Age and Disease Stages

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Backgrounds Alzheimer's disease (AD) is characterized by amyloid‐beta plaques, tau tangles, and neuroinflammation. C‐X3‐C motif chemokine ligand 1 (CX3CL1, also known as fractalkine), a neuroimmune chemokine implicated in AD pathogenesis, shows inconsistent alterations in plasma/serum across studies.
Ling Wang, Yujie Liu, Fei Li, Xuelin Li, Lanlan Li, Jie Zhang, Yali Xu   +6 more
wiley   +1 more source

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Caroline Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative   +19 more
wiley   +1 more source

Real-World Application of Unhealthy Commodity Industries’ Corporate Political Activity Research; Comment on “Corporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy” [PDF]

International Journal of Health Policy and Management
Taxonomies are essential tools for structuring evidence in public health, particularly in rapidly evolving fields like the Commercial Determinants of Health (CDoH).
Francisca Pulido Valente, Hilson Cunha Filho   +1 more
doaj   +1 more source

Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective PIGM encodes a critical enzyme in the glycosylphosphatidylinositol (GPI)‐anchor biosynthesis pathway. While promoter‐region mutations in PIGM have been associated with a relatively mild phenotype characterized by portal vein thrombosis and absence seizures, recent evidence suggests that coding‐region mutations result in a more severe
Júlia Sala‐Coromina, Anna Marcé‐Grau, Barbara Masotto, Marta Codina, Lamia BenJemaa, Yasmina Elaribi, Mónica Martinez‐Gallo, Roger Colobran, Angel Sanchez‐Montañez, Irene Valenzuela, Yoshiko Murakami, Alfons Macaya   +11 more
wiley   +1 more source

Addressing health determinants in a digital age: project report - World Health Organization Regional Office for Europe

The aim of this project was to develop a conceptual framework and provide a common understanding of health determinants in a digital age in light of the emergence of digital determinants of health and the digital transformations of social, political, and
M. Anderson, E. Mossialos, L.E. Seghers, M. Haig, J. Schmidt, G. Monti, D. Novillo-Ortiz, N. Azzopardi-Muscat, G. Wharton, R. Van Kessel, N. Schutte   +10 more
core  

FDG‐PET Associations With Disease Severity and Outcomes in NMDA‐Receptor IgG Autoimmune Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Patients with N‐methyl‐D‐aspartate (NMDA) receptor‐immunoglobulin G (IgG) autoimmune encephalitis (NMDAR‐IgG AE) demonstrate occipital lobe hypometabolism on baseline brain fluorodeoxyglucose‐positron emission tomography (bFDG‐PET).
Jonathan K. Lee, Jeffrey Lambe, Scott Johnson, Akua Abrah, Jennifer Bullen, Jeffrey A. Cohen, Tatchaporn Ongphichetmetha, Amy Kunchok   +7 more
wiley   +1 more source

Why prevention is failing in oral health and a wake up call for rethinking strategies for the world’s most widespread non communicable disease (NCD)

Discover Public Health
Despite decades of evidence demonstrating that dental caries, periodontal disease, and tooth loss are largely preventable, oral diseases remain the most prevalent noncommunicable diseases worldwide.
Hindol Das
doaj   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane, Giorgia Coratti, Chiara Cutrì, Antonio Varone, Riccardo Masson, Adele D'Amico, Valeria Sansone, Sonia Messina, Federica Ricci, Chiara Ticci, Claudio Bruno, Caterina Agosto, Francesca Benedetti, Antonella Pini, Sabrina Siliquini, Massimiliano Filosto, Alberto Zambon, Ilaria Bitetti, Maria Rosaria Manna, Claudia Dosi, Riccardo Zanin, Stefano Parravicini, Roberto De Sanctis, Giulia Stanca, Michela Catteruccia, Michele Tosi, Irene Mizzoni, Emilio Albamonte, Valentina Franchino, Maria Sframeli, Ilaria Cavallina, Elena Procopio, Michele Sacchini, Simone Morando, Noemi Brolatti, Federica Trucco, Gaia Scarpini, Elena Briganti, Beatrice Berti, Concetta Palermo, Daniela Leone, Stefano C. Previtali, Eugenio Mercuri, the ITASMAC working group   +43 more
wiley   +1 more source

Obesonomics

Journal of the Pakistan Medical Association
Economic and commercial determinants of health, as wellas health- related determinants of economy, are graduallybeing understood by researchers and public healthspecialists.
Sanjay Kalra, Madhur Verma, Lakshmi Nagendra, Nitin Kapoor   +3 more
doaj   +1 more source